Bioconjugates of 103Pd nanostructures for targeted Auger electron therapy.
2022/45/B/ST5/01861
Keywords
Descriptors
- ST5_010: Materiały /nanomateriały funkcjonalne, nanocząstki
- ST4_018: Chemia jądrowa i radiacyjna
- NZ7_014: Farmacja, farmakoterapia, farmakologia
Panel
ST5 – Materials: materials synthesis, structure-properties relations, advanced and functional materials with designed properties, (macro)molecular architecture, material engineering
Host institution
Instytut Chemii i Techniki Jądrowej
Voivodeship: mazowieckie
Principal investigator (from the host institution)
dr hab. Agnieszka Majkowska-Pilip
Number of co-investigators in the project: 5
Call
OPUS 23 – announced on 2022-03-28
- Amount awarded
- 1 228 400 PLN
- Project start date
- 2023-02-02
- Project end date
- 2026-02-01
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project completed
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (3)
-
Au@109Pd Core–Shell Nanoparticles Conjugated to Panitumumab for the Combined β−—Auger Electron Therapy of Triple-Negative Breast Cancer
- Authors:
- N. Abassi Gharibkandi, A. Majkowska-Pilip, R. Walczak, M. Wierzbicki, A. Bilewicz
- Academic press:
- Int. J. Mol. Sci. (year: 2024, volume: 24(25), pages: 13555), Publisher: MDPI
- Status:
- Published
- DOI:
- 10.3390/ijms252413555 – link to the publication
-
109Pd/109mAg in-vivo generator in the form of nanoparticles for combined β- - Auger electron therapy of hepatocellular carcinoma
- Authors:
- Nasrin Abbasi Gharibkandi, Kamil Wawrowicz, Rafał Walczak, Agnieszka Majkowska-Pilip, Mateusz Wierzbicki & Aleksander Bilewicz
- Academic press:
- EJNMMI Radiopharmacy and Chemistry (year: 2024, volume: 9, pages: 59-82), Publisher: Springer Open
- Status:
- Published
- DOI:
- 10.1186/s41181-024-00293-9 – link to the publication
-
Au@109Pd core-shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of 109Pd/109mAg in vivo generator in combined β- auger electron therapy
- Authors:
- N. A. Gharibkandi, K. Wawrowicz, A. Majkowska‑Pilip, K. Żelechowska‑Matysiak, M. Wierzbicki and A. Bilewicz
- Academic press:
- EJNMMI Radiopharm Chem . (year: 2023, volume: 8, pages: 26-42), Publisher: Springer Nature Switzerland AG
- Status:
- Published
- DOI:
- 10.1186/s41181-023-00212-4 – link to the publication